SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activationLiangying Zhang(Inner Mongolia Agricultural University), Jianmin Sun(Ningxia Medical University)Scientific ReportsFebruary 8, 202510.1038/s41598-025-89477-0Cited by 2SaveCiteExport RISWatch citationsRelated PapersEntry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors|Cell & Bioscience|2024|1